ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2999

Maternal Microchimerism Is Increased in Multiple Cellular Subsets of Patients with Systemic Sclerosis Compared to Healthy Controls

Sami B. Kanaan1, Whitney Harrington2,3, Laurence S. Loubiere4, Tessa M. Aydelotte1 and J. Lee Nelson1,5, 1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 2Seattle Children's Hospital, Seattle, WA, 3Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, 4University of Birmingham, Birmingham, United Kingdom, 5University of Washington, Seattle, WA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: adaptive immunity, innate immunity and systemic sclerosis, Microchimerism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Microchimerism (Mc) is naturally acquired through bi-directional exchange of small amounts of cells or DNA between mother and fetus during pregnancy. Higher amounts of maternal Mc (MMc) have been reported in peripheral blood of patients suffering from autoimmune diseases such as systemic sclerosis (SSc), compared to healthy controls (1,2), however, it is unknown what cell type(s) is responsible for this increase. We investigated the frequencies and quantitative levels of MMc within cellular subsets isolated from peripheral blood mononuclear cells (PBMC) in patients with SSc and compared results to healthy controls.

Methods : 69 subjects were studied for MMc in T cells, B cells, NK cells and monocyte/macrophages, including 27 female patients with SSc and 42 healthy controls (32 female and 10 male). To detect and identify MMc, HLA-specific primers and fluorogenic probes were used in quantitative polymerase chain reaction (Q-PCR), targeting the non-inherited, non-shared maternal HLA allele. Therefore, HLA genotyping was performed for all the subjects and their mothers. When non-inherited maternal HLA was indistinguishable from subject’s HLA, primers and probes targeting non-HLA polymorphisms developed for this purpose were used. Using fluorescence-activated cell sorting, PBMC were sorted into: T, B, and NK cells, and monocyte/macrophages to an average purity of 98.6%. The specific Q-PCR assays were then undertaken on DNA extracted from individual subsets. Prevalence of MMc was analyzed using logistic regression, and negative binomial regression model was used to asses MMc quantitative levels, with adjustment for total number of genome equivalents tested.

Results: MMc was identified in at least one cellular subset in 44.4% of SSc patients and 40.5% of healthy subjects, without a significant difference between patients and controls overall, or when comparing each subpopulation separately. However, MMc levels were significantly higher in SSc patients compared to controls, with an incidence rate ratio (IRR) of 47.4 (P < 0.001). Interestingly, the difference in MMc levels was greater in the adaptive immune subpopulations (IRR[T cells] = 109.1 and IRR[B cells] = 51.2; P < 0.001) compared to those of the innate immune cells (IRR[NK cells] = 29.8; P = 0.001 and IRR[Monocytes] = 6.3; P = 0.117).

Conclusion : We found higher amounts of MMc especially in adaptive immune cellular subsets in women with SSc compared to healthy controls. This incites further investigation of the immunologic functionality of MMc in health and disease, which is currently under way.

References:

  1. Lambert, et al. Arthritis Rheum. 2004 Mar;50(3):906-14
  2. Nelson JL. Trends Immunol. 2012 Aug;33(8):421-7

Disclosure: S. B. Kanaan, None; W. Harrington, None; L. S. Loubiere, None; T. M. Aydelotte, None; J. L. Nelson, None.

To cite this abstract in AMA style:

Kanaan SB, Harrington W, Loubiere LS, Aydelotte TM, Nelson JL. Maternal Microchimerism Is Increased in Multiple Cellular Subsets of Patients with Systemic Sclerosis Compared to Healthy Controls [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/maternal-microchimerism-is-increased-in-multiple-cellular-subsets-of-patients-with-systemic-sclerosis-compared-to-healthy-controls/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/maternal-microchimerism-is-increased-in-multiple-cellular-subsets-of-patients-with-systemic-sclerosis-compared-to-healthy-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology